BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 7010526)

  • 1. Gastric inhibitory polypeptide (GIP) and insulin release after small-bowel resection in man.
    Lauritsen KB; Moody AJ; Christensen KC; Lindkaer Jensen S
    Scand J Gastroenterol; 1980; 15(7):833-40. PubMed ID: 7010526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric inhibitory polypeptide (GIP) release and incretin effect after oral glucose in obesity and after jejunoileal bypass.
    Lauritsen KB; Christensen KC; Stokholm KH
    Scand J Gastroenterol; 1980; 15(4):489-95. PubMed ID: 7001614
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
    Nauck MA; Siemsglüss J; Orskov C; Holst JJ
    Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gastric inhibitory polypeptide (GIP) and insulin release in response to oral and intravenous glucose in uremic patients.
    Lauritzen JB; Lauritsen KB; Olsen ME; Timmerman I
    Metabolism; 1982 Nov; 31(11):1096-9. PubMed ID: 6752641
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gastric inhibitory polypeptide and insulin release in response to oral and intravenous glucose in coeliac disease.
    Lauritsen KB; Lauritzen JB; Christensen KC
    Scand J Gastroenterol; 1982 Mar; 17(2):241-5. PubMed ID: 6753103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The response of gastric inhibitory polypeptide (GIP) and insulin to glucose in duodenal ulcer patients.
    Lauritsen KB; Moody AJ
    Diabetologia; 1978 Mar; 14(3):149-53. PubMed ID: 658630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of massive small bowel resection (MSBR) and small intestinal bypass (JIB) in the rat on the enteroinsular axis.
    Buchan AM; Pederson RA; Chan CB; Brown JC
    Regul Pept; 1983 Nov; 7(3):221-32. PubMed ID: 6364262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between plasma GIP and insulin after oral glucose.
    Lauritsen KB; Moody AJ
    Scand J Gastroenterol; 1980; 15(8):953-7. PubMed ID: 7015475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of gastric inhibitory polypeptide in totally pancreatectomized patients.
    Miyata M; Izukura M; Hamaji M; Nakao K; Kawashima Y
    J Clin Endocrinol Metab; 1985 Jun; 60(6):1261-4. PubMed ID: 3889032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gastric inhibitory polypeptide (GIP) response to an oral glucose load in the patients with diabetes mellitus.
    Nakanome C; Akai H; Umezu M; Toyota T; Goto Y
    Tohoku J Exp Med; 1983 Mar; 139(3):287-92. PubMed ID: 6344327
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
    Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
    Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The response of plasma gastric-inhibitory polypeptide (GIP) to slow and fast glucose ingestion in Billroth II resected patients and normal controls.
    Jorde R; Schulz TB; Burhol PG; Schulz LB
    Regul Pept; 1981 Nov; 2(6):391-9. PubMed ID: 7029674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Release of gastric inhibitory polypeptide (GIP) during calcium infusion and in hyperparathyroidism.
    Toyota T; Nakanome C; Akai H; Umezu M; Goto Y
    Regul Pept; 1982 Jun; 4(1):1-12. PubMed ID: 6750703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of graded intraduodenal glucose infusions on the release and physiological action of gastric inhibitory polypeptide.
    McCullough AJ; Miller LJ; Service FJ; Go VL
    J Clin Endocrinol Metab; 1983 Feb; 56(2):234-41. PubMed ID: 6337173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of increasing doses of ingested glucose on insulin and gastric inhibitory polypeptide (GIP) concentrations in man.
    Falko JM; Crockett SE; Cataland S; O'Dorisio TM; Kramer W; Mazzaferri EL
    Clin Endocrinol (Oxf); 1980 Dec; 13(6):587-93. PubMed ID: 7014042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Localization of gastric inhibitory polypeptide release by intestinal glucose perfusion in man.
    Thomas FB; Shook DF; O'Dorisio TM; Cataland S; Mekhjian HS; Caldwell JH; Mazzaferri EL
    Gastroenterology; 1977 Jan; 72(1):49-54. PubMed ID: 830237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diminished gastric inhibitory polypeptide response to oral glucose in late human pregnancy.
    Hornnes PJ; Kühl C; Lauritsen KB
    J Clin Endocrinol Metab; 1979 Mar; 48(3):506-8. PubMed ID: 429501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose-induced GIP levels in patients with insulinoma.
    Tamburrano G; Lala A; Mauceri M; Leonetti F; Andreani D
    Horm Metab Res; 1984 Dec; 16 Suppl 1():200-3. PubMed ID: 6099816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Different response of gastric inhibitory polypeptide to glucose and fat from duodenum and jejunum.
    Schattenmann G; Ebert R; Siewert R; Creutzfeldt W
    Scand J Gastroenterol; 1984 Mar; 19(2):260-6. PubMed ID: 6372074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GLP-1 and GIP Levels in Patients With Hyperthyroidism: The Effect of Antithyroid Treatment.
    Cira DK; Sari R; Ozdem S; Yilmaz N; Bozkurt S
    Ann Pharmacother; 2017 Aug; 51(8):663-668. PubMed ID: 28452237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.